Australia's Orthocell surges to near 5-month high on record quarterly revenue

Orthocell

02/10/2025 02:01

** Shares of Australia's Orthocell OCC.AX rise as much as 11.5% to A$1.6, their highest since May 6

** Regenerative medicine firm posts record revenue of A$3 million ($1.98 million) for the quarter ended September 30 vs A$2 million in the same quarter last year

** Attributes record revenue to increasing market penetration of nerve repair product Remplir in Australia and Singapore

** About 1.4 mln shares change hands; nearly 2.3x 30-day average

** OCC up 14.4%, YTD

($1 = 1.5135 Australian dollars)

 (Reporting by Keshav Singh Chundawat in Bengaluru)

 ((Keshav.singhchundawat@thomsonreuters.com))